Gewert D R, Moore G, Clemens M J
Biochem J. 1983 Sep 15;214(3):983-90. doi: 10.1042/bj2140983.
Inhibition of the proliferation of Daudi cells by exposure to human lymphoblastoid interferons is associated with an early and marked decrease in the incorporation into DNA of exogenous [3H]thymidine when cells are incubated with trace amounts of this precursor. In contrast, incorporation of exogenous deoxyadenosine into DNA is unchanged under the same conditions. Interferon treatment results in a lowering of thymidine kinase activity, an effect which may be largely responsible for the inhibition of incorporation of labelled thymidine into DNA. At higher concentrations of exogenous thymidine, which minimize the contribution of intracellular sources to the dTTP pool, the inhibition of thymidine incorporation is abolished. Under conditions in which exogenous thymidine is rigorously excluded from the medium or, conversely, in which cells are entirely dependent on exogenous thymidine for growth, the magnitude of the inhibition of cell proliferation by interferons is the same as under normal culture conditions. We conclude that, even though cell growth is impaired, the rate of DNA synthesis is not grossly inhibited up to 48 h after commencement of interferon treatment. Furthermore, changes in neither the utilization of exogenous thymidine nor the synthesis of nucleotides de novo are responsible for the effect on cell proliferation.
当用人淋巴母细胞干扰素处理Daudi细胞时,细胞增殖受到抑制,这与在细胞与微量外源性[3H]胸腺嘧啶核苷一起孵育时,外源性[3H]胸腺嘧啶核苷掺入DNA的量早期显著减少有关。相比之下,在相同条件下,外源性脱氧腺苷掺入DNA的量没有变化。干扰素处理导致胸腺嘧啶激酶活性降低,这一效应可能在很大程度上是抑制标记胸腺嘧啶核苷掺入DNA的原因。在较高浓度的外源性胸腺嘧啶核苷下,细胞内来源对dTTP池的贡献最小,此时胸腺嘧啶核苷掺入的抑制作用被消除。在培养基中严格排除外源性胸腺嘧啶核苷的条件下,或者相反,在细胞完全依赖外源性胸腺嘧啶核苷生长的条件下,干扰素对细胞增殖的抑制程度与正常培养条件下相同。我们得出结论,即使细胞生长受到损害,在开始干扰素处理后的48小时内,DNA合成速率也没有受到严重抑制。此外,外源性胸腺嘧啶核苷利用的变化以及核苷酸从头合成的变化都不是对细胞增殖产生影响的原因。